These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35741027)

  • 41. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.
    Lou WZ; Jiang F; Hu J; Chen XX; Song YN; Zhou XY; Liu JT; Bian XM; Gao JS
    Dis Markers; 2019; 2019():6270187. PubMed ID: 31396294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIF‑3α affects preeclampsia development by regulating EVT growth via activation of the Flt‑1/JAK/STAT signaling pathway in hypoxia.
    Qu H; Yu Q; Jia B; Zhou W; Zhang Y; Mu L
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33215219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific HIF-2α (Hypoxia-Inducible Factor-2) Inhibitor PT2385 Mitigates Placental Dysfunction In Vitro and in a Rat Model of Preeclampsia (RUPP).
    Colson A; Depoix CL; Lambert I; Leducq C; Bedin M; De Beukelaer M; Gatto L; Loriot A; Peers de Nieuwburgh M; Bouhna K; Baldin P; Hubinont C; Sonveaux P; Debiève F
    Hypertension; 2023 May; 80(5):1011-1023. PubMed ID: 36876500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In Vitro Induction of Hypoxia/Reoxygenation on Placental Cells: A Suitable Model for Understanding Placental Diseases.
    Sagrillo-Fagundes L; Laurent L; Bienvenue-Pariseault J; Vaillancourt C
    Methods Mol Biol; 2018; 1710():277-283. PubMed ID: 29197010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.
    Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A
    Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Placental hypoplasia and maternal organic vascular disorder in pregnant women with gestational hypertension and preeclampsia.
    Owaki Y; Watanabe K; Iwasaki A; Saitou T; Matsushita H; Wakatsuki A
    J Matern Fetal Neonatal Med; 2021 Feb; 34(3):353-359. PubMed ID: 30983440
    [No Abstract]   [Full Text] [Related]  

  • 47. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α.
    Murphy SR; LaMarca BB; Parrish M; Cockrell K; Granger JP
    Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(2):R130-5. PubMed ID: 23193111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia.
    Yong Q; Dijkstra KL; van der Keur C; Bruijn JA; Eikmans M; Baelde HJ
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total Versus Free Placental Growth Factor Levels in the Pathogenesis of Preeclampsia.
    Lecarpentier E; Zsengellér ZK; Salahuddin S; Covarrubias AE; Lo A; Haddad B; Thadhani RI; Karumanchi SA
    Hypertension; 2020 Sep; 76(3):875-883. PubMed ID: 32654553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.
    Nevo O; Soleymanlou N; Wu Y; Xu J; Kingdom J; Many A; Zamudio S; Caniggia I
    Am J Physiol Regul Integr Comp Physiol; 2006 Oct; 291(4):R1085-93. PubMed ID: 16627691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia.
    Trapiella-Alfonso L; Alexandre L; Fraichard C; Pons K; Dumas S; Huart L; Gaucher JF; Hebert-Schuster M; Guibourdenche J; Fournier T; Vidal M; Broutin I; Lecomte-Raclet L; Malaquin L; Descroix S; Tsatsaris V; Gagey-Eilstein N; Lecarpentier E
    Hypertension; 2019 Jul; 74(1):145-153. PubMed ID: 31079531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
    Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
    PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARγ/sFlt-1 axis in preeclampsia.
    Liu L; Wang R; Xu R; Chu Y; Gu W
    Pharmacol Res; 2022 Mar; 177():106127. PubMed ID: 35150862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia.
    Luo X; Yao ZW; Qi HB; Liu DD; Chen GQ; Huang S; Li QS
    Cell Tissue Res; 2011 Jun; 344(3):551-65. PubMed ID: 21519896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.
    Palmer KR; Tong S; Tuohey L; Cannon P; Ye L; Hannan NJ; Brownfoot FC; Illanes SE; Kaitu'u-Lino TJ
    Biol Reprod; 2016 Mar; 94(3):59. PubMed ID: 26819475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies.
    Hoeller A; Ehrlich L; Golic M; Herse F; Perschel FH; Siwetz M; Henrich W; Dechend R; Huppertz B; Verlohren S
    Hypertens Pregnancy; 2017 May; 36(2):151-160. PubMed ID: 28609172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.